References
- Murphy S B. Pediatric lymphomas: recent advances and commentary on Ki-1-positive anaplastic large-cell lymphomas of childhood. Annals of Oncology 1994; 5(Supplement 1)S31–S33
- Magrath I T. Malignant non-Hodgkin's lymphomas in children. Hematology Oncology Clinics of North America 1987; 1(4)577–602
- Writing Committee. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49: 212–2135
- Hutchison R, Fairclough E., Holt L. D, et al. Clinical significance of histology and immunophenotype in childhood diffuse large cell lymphoma. American Journal of Clinical Pathology 1991; 95: 787–793
- Hvizdala E, Berard V., Callihan C. T., et al. Nonlymphoblastic lymphoma in children—histology and stage-related response to therapy: a Pediatric Oncology Group study. Journal of Clinical Oncology 1991; 9: 1189–1195
- Weinstein H, Lack J. EE, Cassady J R. APO therapy for malignant lymphoma of large cell “histiocytic” type of childhood: analysis of treatment results for 29 patients. Blood 1984; 64: 422–426
- Sullivan M, Brecher P., Ramirez M. I., et al. High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study. American Journal of Pediatric Hematology Oncology 1991; 13: 288–295
- Fisher R, Gaynor I., Dahlberg R. E. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New England Journal of Medicine 1993; 328: 1002–1009
- Balis F, Holcenberg M. JS, Poplack D G. General principles of chemotherapy. Principles and Practice of Pediatric Oncology, P A Pizzo, D G Poplack. Lippincott-Raven, Philadelphia, PA 1997; 227–230
- Murphy S B. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: Dissimilarities from lymphomas in adults. Seminars in Oncology 1980; 7: 332–339
- Hutchison R, Berard E., Shuster W. C. B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: a Pediatric Oncology Group study. Journal of Clinical Oncology 1995; 13: 2023–2032
- Kaplan E, Meier L. Nonparametric estimation from incomplete observations. Journal of American Statistical Association 1958; 35: 457–481
- Peto Pike R., Armitage C. MP., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. JJ. Analysis and examples. British Journal of Cancer 1977; 35: 1–39
- Brugieres Deley L., Pacquement C. MH., et al. CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood 1998; 92: 3591–3598
- Reiter Schrappe A., Tiemann M. M., et al. Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. Journal of Clinical Oncology 1994; 12: 899–908
- Pane Philip C., Rodary T. C., et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children. Journal of Clinical Oncology 1991; 9: 123–132
- Chilcotte R, Krailo R., Kjeeldsky M. C., et al. Daunomycin plus COMP vs COMP therapy in childhood non-Hodgkin's lymphoma. ASCO Proceedings 1991; 209
- Fisher Anderson B., De S., Cillis A., et al. Further evaluation of intensified and increased dose of cyclophosphamide for the treatment of primary breast cancer: Findings from the National Surgical Adjuvant Breast and Bowel Project B-25. Journal of Clinical Oncology 1999; 11: 3374–3388
- Bunin N, Hvizdala J., Link E., Callihan M., Hustu R. T, Wharam O. H, Warnke M., Berard A. RCW., Murphy S B. Mediastinal nonlymphoblastic lymphomas in children: a clinicopathologic study. Journal of Clinical Oncology 1986; 4: 154–159
- Lippman S, Miller M., Spier P. T. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype. Blood 1988; 72: 436–441
- Hutchison R, Banki E., Shuster K. JJ., et al. Use of an anti-ALK antibody in the characterization of anaplastic large cell lymphoma of childhood. Annals of Oncology 1997; 5: S37–S37, (Supplement 1)
- Reiter Schrappe A., Tiemann M. M., et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood 1999; 94: 3294–3306
- Reiter Schrappe A., Parwaresch M. R., et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage-a report of the Berlin-Frankfurt-Munster Group. Journal of Clinical Oncology 1995; 13: 359–372
- Hams N, Jaffe L., Stein S. E. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study. Blood 1994; 84: 1361–1392